Biondvax Pharmaceuticals Limited Ads (NASDAQ:BVXV)’s Trend Unknown, Especially After Increased Shorts

June 19, 2017 - By Adrian Mccoy

 Biondvax Pharmaceuticals Limited Ads (NASDAQ:BVXV)’s Trend Unknown, Especially After Increased Shorts

The stock of Biondvax Pharmaceuticals Limited Ads (NASDAQ:BVXV) registered an increase of 94.84% in short interest. BVXV’s total short interest was 30,200 shares in June as published by FINRA. Its up 94.84% from 15,500 shares, reported previously. With 32,000 shares average volume, it will take short sellers 1 days to cover their BVXV’s short positions. The short interest to Biondvax Pharmaceuticals Limited Ads’s float is 1.16%.

About 42,493 shares traded or 65.51% up from the average. BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ:BVXV) has risen 97.97% since June 19, 2016 and is uptrending. It has outperformed by 81.27% the S&P500.

BiondVax Pharmaceuticals Ltd is an Israel biopharmaceutical company. The company has market cap of $34.28 million. The Firm holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing the flu vaccine. It currently has negative earnings. BiondVax Pharmaceuticals Ltd develops a biopharmaceutical universal flu vaccine, designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains.

More news for BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ:BVXV) were recently published by: Benzinga.com, which released: “22 Stocks Moving In Monday’s Pre-Market Session” on May 15, 2017. Marketwatch.com‘s article titled: “7.80” and published on May 12, 2015 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.